Breaking News Instant updates and real-time market news.

MDT

Medtronic

$85.29

0.305 (0.36%)

, MCK

McKesson

$146.84

0.39 (0.27%)

20:25
05/23/18
05/23
20:25
05/23/18
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Medtronic (MDT), consensus $1.39... McKesson (MCK), consensus $3.56... Best Buy (BBY), consensus 74c... Hormel Foods (HRL), consensus 45c... Toro Company (TTC), consensus $1.21... Sanderson Farms (SAFM), consensus $2.20.

MDT

Medtronic

$85.29

0.305 (0.36%)

MCK

McKesson

$146.84

0.39 (0.27%)

BBY

Best Buy

$75.73

0.255 (0.34%)

HRL

Hormel Foods

$35.82

-0.01 (-0.03%)

TTC

Toro Company

$60.32

-0.08 (-0.13%)

SAFM

Sanderson Farms

$107.13

1.19 (1.12%)

  • 24

    May

  • 24

    May

  • 24

    May

  • 24

    May

  • 24

    May

  • 29

    May

  • 30

    May

  • 02

    Jun

  • 05

    Jun

  • 12

    Jun

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

MDT Medtronic
$85.29

0.305 (0.36%)

05/21/18
RHCO
05/21/18
NO CHANGE
Target $96
RHCO
Buy
Medtronic price target raised to $96 from $92 at SunTrust
SunTrust analyst Bruce Nudell raised his price target on Medtronic to $96, adjusting his model for the divestment of the company's patient monitoring and recovery business. The analyst also keeps his Buy rating ahead of this week's earnings, forecasting organic mid-single-digit sales growth, modest margin expansion, and share buybacks driving high-single digit growth in earnings.
04/27/18
PIPR
04/27/18
INITIATION
Target $90
PIPR
Overweight
Medtronic assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Matt O'Brien assumed coverage of Medtronic with an Overweight rating and $90 price target. While slower end markets and share erosion in certain areas are risks to monitor, the stock does not reflect the company's upcoming product cycle, which is "quite strong," O'Brien tells investors in a research note. Further, he sees "considerable margin expansion" in front of the company. The analyst encourages investors to start or build positions in Medtronic.
04/17/18
PIPR
04/17/18
NO CHANGE
PIPR
J&J commentary positive for pure-play spine names, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien is out discussing derivative calls following Johnson & Johnson's (JNJ) Q1 results. The orthopedic market looked relatively stable, though Hips were notably softer than expected, O'Brien tells investors in a research note. He believes Stryker (SYK) is "clearly taking market share," which he views as an incremental negative for Zimmer Biomet (ZBH). On Spine, some U.S. weakness was expected, but J&J's results could be viewed as concerning given continued weakness since Q3 of 2017, the analyst adds. He thinks the end markets "are ok" and the commentary on J&J losing share benefits pure-play spine names NuVasive (NUVA), Globus Medical (GMED), SeaSpine (SPNE) and K2M Group (KTWO). He believes the pure-plays continue to out-innovate and take share despite the weakness in the overall category. Johnson & Johnson's results also show that the U.S. lens market remains strong and is shifting to 1-Days lenses from weeklies/monthlies, which is a positive for Cooper Companies (COO), O'Brien contends. Lastly, the analyst says the decline in J&J's U.S. diabetes franchise from the Animas exit was faster than expected. This is good for the pump names Insulet (PODD) and Tandem Diabetes (TNDM) and a slight negative for Dexcom (DXCM) as some of those will end up at Medtronic (MDT), O'Brien argues. He continues to believe that both Insulet and Tandem "will gain more than their fair share" of Animas patients.
04/16/18
JPMS
04/16/18
NO CHANGE
JPMS
Overweight
Intuitive Surgical momentum shows no signs of slowing, JPMorgan
After attending the Society of American Gastrointestinal and Endoscopic Surgeons annual meeting, JPMorgan analyst Tycho Peterson believes Intuitive Surgical's (ISRG) momentum is showing no signs of slowing. However, the stock may take a breather after rallying 14% year-to-date given the Medtronic (MDT) overhang into the June analyst day, Peterson tells investors in a research note. Nevertheless, he continues to like the longer-term set-up and reiterates an Overweight rating on the shares. The analyst says momentum remains strong in robotic general surgery. Further, there was little new on the competitive front at the meeting, as Medtronic and Johnson & Johnson (JNJ) deferred commentary on robotic systems ahead oftheir upcoming analyst days, Peterson points out.
MCK McKesson
$146.84

0.39 (0.27%)

04/17/18
MZHO
04/17/18
NO CHANGE
MZHO
Amazon news removes 'unprecedented overhang' on drug sellers, says Mizuho
After CNBC reported yesterday afternoon that Amazon (AMZN) has decided to shelve its plan to sell and distribute pharmaceutical products, Mizuho analyst Ann Hynes said she had thought Amazon's current logistics and distribution model would not translate into healthcare. However, based on conversations with investors, she believes the magnitude of the overhang that Amazon presented for drug distributors and retail pharmacies was "unprecedented." While drug pricing is still a concern, she notes that the CNBC report removes one overhang on the drug supply chain stocks. Hynes remain a buyer of CVS Health (CVS) and Walgreens (WBA) and keeps Neutral ratings on Rite Aid (RAD) as well as on drug distributors AmerisourceBergen (ABC), Cardinal Health (CAH) and McKesson (MCK).
02/27/18
BOFA
02/27/18
INITIATION
Target $179
BOFA
Buy
McKesson reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Michael Cherny reinstated coverage on McKesson with a Buy and $179 price target.
03/08/18
LEHM
03/08/18
INITIATION
Target $165
LEHM
Equal Weight
McKesson initiated with an Equal Weight at Barclays
Barclays analyst Steve Valiquette started McKesson with an Equal Weight rating and $165 price target. The analyst initiated 14 companies in Health Care Services with a Neutral industry view.
02/27/18
BOFA
02/27/18
INITIATION
Target $179
BOFA
McKesson reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Michael Cherny reinstated coverage on McKesson with a Buy and $179 price target.
BBY Best Buy
$75.73

0.255 (0.34%)

05/21/18
JEFF
05/21/18
NO CHANGE
Target $79
JEFF
Hold
Best Buy Q1 comp estimate raised to 6% from 3.5% at Jefferies
To reflect channel checks and "strong" industry data, Jefferies analyst Daniel Binder raised his Q1 comp sales estimate for Best Buy to 6.0% from 3.5%. "Strong" underlying trends against easy comparisons allowed Best Buy to overcome the headwinds of lapping tough gaming comps, Binder tells investors in a research note. Further, he believes that government data suggest his estimates could prove conservative. The analyst expects a good Q1 from Best Buy and upped his price target for the shares to $79 from $74. Binder keeps a Hold rating on the stock.
04/17/18
PIPR
04/17/18
NO CHANGE
Target $89
PIPR
Overweight
Supreme Court case could be 'sneaky positive' for Best Buy, says Piper Jaffray
The pending Supreme Court case, South Dakota versus Wayfair (W), could be a "sneaky positive" for Best Buy (BBY) should the Supreme Court rule in favor of South Dakota, Piper Jaffray analyst Peter Keith tells investors in a research note. A rule in favor of South Dakota, which the analyst expects, would allow states to start collecting sales tax on e-commerce purchases. Sales tax has become less of a factor for purchasing decisions, but it still matters for big-ticket, branded items, Keith contends. He reiterates an Overweight rating on Best Buy with an $89 price target.
04/23/18
WELS
04/23/18
INITIATION
Target $77
WELS
Market Perform
Best Buy initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Zachary Fadem started Best Buy with a Market Perform rating and $77 price target.
04/03/18
MSCO
04/03/18
NO CHANGE
Target $115
MSCO
Overweight
If history holds, Lowe's could outperform after CEO change, says Morgan Stanley
Following the announcement of a CEO transition at Lowe's (LOW), Morgan Stanley analyst Simeon Gutman looked at recent management changes at two large-cap Hardline retailers - Best Buy (BBY) and Advance Auto Parts (AAP) - as case studies searching for signs of what to expect at the home improvement retailer. While acknowledging that each situation is unique, Gutman also pointed out what he sees as "a few interesting similarities." The analyst noted that Best Buy had a tough first three months following the installment of Hubert Joly, but then the stock increased 200% in the following nine months, leaving the stock up 100% in the first 12 months of Joly's tenure. Advance Auto also initially dipped in the month following the onboarding of CEO Tom Greco, but then it rose 21% in the next seven months, noted Gutman. The analyst, who also noted that Lowe's multiple on 2019 EPS estimates is among the lowest compared to nearly all large cap retailers, keeps his Overweight rating on the shares.
HRL Hormel Foods
$35.82

-0.01 (-0.03%)

01/04/18
PIPR
01/04/18
INITIATION
Target $42
PIPR
Overweight
Hormel Foods assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Brett Wong assumed coverage of Hormel Foods with an Overweight rating and $42 price target. The analyst expects continued strong top-line growth, both organic and from acquisitions, and considers the company's portfolio attractive.
02/14/18
JEFF
02/14/18
UPGRADE
Target $38
JEFF
Buy
Hormel Foods upgraded to Buy from Hold at Jefferies
Jefferies analyst Akshay Jagdale upgraded Hormel Foods (HRL) to Buy with an increased price target of $38. The analyst believes the company has a "solid platform for accretive acquisitions." He also has an improved outlook for pork packer margins.
03/23/18
SPHN
03/23/18
NO CHANGE
SPHN
Stephens says to buy Hormel Foods, Tyson Foods on China trade headlines
Stephens analyst Farha Aslam recommends buying Hormel Foods (HRL) and Tyson Foods (TSN) on headlines of a Chinese 25% tariff on US pork. Aslam said China imports only about 2-3% of U.S. pork production, which is insignificant and can be absorbed by other markets.
01/04/18
PIPR
01/04/18
INITIATION
Target $42
PIPR
Overweight
Hormel Foods assumed with an Overweight at Piper Jaffray
Piper Jaffray assumed coverage of Hormel Foods with an Overweight rating and $42 price target.
TTC Toro Company
$60.32

-0.08 (-0.13%)

08/25/17
GHSC
08/25/17
DOWNGRADE
Target $67
GHSC
Neutral
Toro Company downgraded to Neutral from Buy at Seaport Global
Seaport Global analyst Michael Shlisky downgraded Toro Company to Neutral and lowered its price target to $67 from $75 following the Q3 report saying most of the earnings beat came from a lower-than-expected tax rate and believes investors have come to expect more operating upside each quarter and the stock sold off as a result.
08/25/17
DOTC
08/25/17
DOWNGRADE
DOTC
Neutral
Toro Company downgraded to Neutral from Buy at Dougherty
05/14/18
CLVD
05/14/18
DOWNGRADE
CLVD
Neutral
Toro Company downgraded to Neutral from Buy at Cleveland Research
SAFM Sanderson Farms
$107.13

1.19 (1.12%)

02/21/18
BUCK
02/21/18
INITIATION
Target $122
BUCK
Neutral
Sanderson Farms initiated with a Neutral at Buckingham
Buckingham analyst Eric Larson initiated Sanderson Farms with a Neutral and $122 saying he is more cautious on 2019-20 fundamentals due to potential substantial industry capacity expansion and limited benefits from feed costs. Larson views valuation as fair near-term and sees risk/reward balance as skewed to the downside given earnings sensitivity to an unfavorable turn in the ag cycle.
02/21/18
02/21/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tyson Foods (TSN) initiated with a Neutral at Buckingham. 2. Sanderson Farms (SAFM) initiated with a Neutral at Buckingham. 3. CF Industries (CF) initiated with an Outperform at Bernstein. 4. Anthera (ANTH) initiated with a Buy at Roth Capital. 5. Corporate Capital Trust (CCT) initiated with an Outperform at Wells Fargo. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/23/18
JPMS
02/23/18
NO CHANGE
Target $110
JPMS
Underweight
Sanderson Farms price target lowered to $110 from $132 at JPMorgan
JPMorgan analyst Ken Goldman lowered his price target for Sanderson Farms to $110 following yesterday's earnings call and keeps an Underweight rating on the name. The analyst views the company's goal of fiscal 2018 EBIT margin over 12% as unrealistic. Goldman's not convinced that recent weather-driven supply dislocations fully explain weak breast prices. He notes that prices have been soft since last August. The analyst keeps an Underweight rating on Sanderson Farms.
02/28/18
VERF
02/28/18
UPGRADE
VERF
Buy
Sanderson Farms upgraded to Buy from Hold at Vertical Group

TODAY'S FREE FLY STORIES

BHP

BHP Billiton

$47.63

-1.34 (-2.74%)

21:07
06/19/18
06/19
21:07
06/19/18
21:07
Periodicals
BHP to sell Cerro Colorado copper mine to EMR Capital for $230M, Reuters says »

BHP has reached an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALA

Kala Pharmaceuticals

$13.38

-0.36 (-2.62%)

21:04
06/19/18
06/19
21:04
06/19/18
21:04
Recommendations
Kala Pharmaceuticals analyst commentary at Wells Fargo »

Kala Pharma's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

CAFD

8point3 Energy

$12.42

0.01 (0.08%)

20:21
06/19/18
06/19
20:21
06/19/18
20:21
Hot Stocks
8point3 Energy closes merger transaction »

8point3 Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$46.29

-0.25 (-0.54%)

20:15
06/19/18
06/19
20:15
06/19/18
20:15
Recommendations
Oracle analyst commentary at MUFG »

Oracle cloud business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

TLSYY

Telstra

$0.00

(0.00%)

20:01
06/19/18
06/19
20:01
06/19/18
20:01
Hot Stocks
Telstra sees FY19 EBITDA $8.7B-$9.4B »

To cut 8,000 staff and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXC

Exelon

$41.61

-0.11 (-0.26%)

, FSLR

First Solar

$52.21

0.39 (0.75%)

19:52
06/19/18
06/19
19:52
06/19/18
19:52
Periodicals
First Solar, Exelon push for carbon tax legislation, Bloomberg reports »

Exelon (EXC) has…

EXC

Exelon

$41.61

-0.11 (-0.26%)

FSLR

First Solar

$52.21

0.39 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLXN

Flexion

$27.40

0.63 (2.35%)

, ANIK

Anika Therapeutics

$45.99

0.9 (2.00%)

19:21
06/19/18
06/19
19:21
06/19/18
19:21
Recommendations
Flexion, Anika Therapeutics analyst commentary at Wells Fargo »

Flexion to benefit from…

FLXN

Flexion

$27.40

0.63 (2.35%)

ANIK

Anika Therapeutics

$45.99

0.9 (2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

ENSG

Ensign Group

$38.55

0.06 (0.16%)

19:07
06/19/18
06/19
19:07
06/19/18
19:07
Hot Stocks
Ensign Group subsidiary acquires office building in San Juan Capistrano »

The Ensign Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNOV

MediciNova

$8.37

-0.03 (-0.36%)

19:01
06/19/18
06/19
19:01
06/19/18
19:01
Hot Stocks
MediciNova receives Notice of Allowance from JPO for new patent covering MN-001 »

MediciNova announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAESY

BAE Systems

$0.00

(0.00%)

19:00
06/19/18
06/19
19:00
06/19/18
19:00
Hot Stocks
USMC awards BAE Systems $198M amphibious combat vehicle contract »

The U.S. Marine Corps has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$228.20

-3.185 (-1.38%)

18:59
06/19/18
06/19
18:59
06/19/18
18:59
Periodicals
Goldman plans to invest $500M in women-run companies, Reuters says »

Goldman Sachs intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

NTIP

Network-1 Technologies

$3.00

(0.00%)

, SYNA

Synaptics

$48.81

-0.35 (-0.71%)

18:50
06/19/18
06/19
18:50
06/19/18
18:50
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Network-1…

NTIP

Network-1 Technologies

$3.00

(0.00%)

SYNA

Synaptics

$48.81

-0.35 (-0.71%)

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

PRTA

Prothena

$14.99

0.43 (2.95%)

LZB

La-Z-Boy

$33.25

0.1 (0.30%)

ORCL

Oracle

$46.29

-0.25 (-0.54%)

FDX

FedEx

$258.35

-5.295 (-2.01%)

ANIK

Anika Therapeutics

$45.99

0.9 (2.00%)

KIN

Kindred Biosciences

$10.00

-0.55 (-5.21%)

SBUX

Starbucks

$57.43

0.22 (0.38%)

GE

General Electric

$12.96

-0.24 (-1.82%)

VALE

Vale

$12.97

-0.21 (-1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 19

    Jun

  • 19

    Jun

  • 22

    Jun

  • 28

    Jun

  • 09

    Jul

  • 10

    Jul

  • 12

    Jul

  • 20

    Sep

  • 21

    Sep

  • 20

    Jun

SD

SandRidge Energy

$17.03

1.21 (7.65%)

, IEP

Icahn Enterprises

$72.11

-0.62 (-0.85%)

18:44
06/19/18
06/19
18:44
06/19/18
18:44
Hot Stocks
SandRidge Energy reaches pact with Icahn Capital on board composition »

SandRidge Energy (SD)…

SD

SandRidge Energy

$17.03

1.21 (7.65%)

IEP

Icahn Enterprises

$72.11

-0.62 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$106.20

-0.85 (-0.79%)

18:32
06/19/18
06/19
18:32
06/19/18
18:32
Hot Stocks
Disney names Jennifer lee Walt Disney Animation Studios CCO »

Disney announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRIL

Trillium Therapeutics

$6.20

0.05 (0.81%)

18:32
06/19/18
06/19
18:32
06/19/18
18:32
Syndicate
Trillium Therapeutics announces 'at-the-market' issuance program »

Trillium Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$32.39

0.19 (0.59%)

, GOOG

Alphabet

$1,167.86

-5.77 (-0.49%)

18:17
06/19/18
06/19
18:17
06/19/18
18:17
Periodicals
AT&T in discussions to purchase AppNexus, Cheddar reports »

AT&T (T) is in talks…

T

AT&T

$32.39

0.19 (0.59%)

GOOG

Alphabet

$1,167.86

-5.77 (-0.49%)

GOOGL

Alphabet Class A

$1,178.29

-5.69 (-0.48%)

FB

Facebook

$197.46

-0.84 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Oct

AAL

American Airlines

$41.51

-0.93 (-2.19%)

18:14
06/19/18
06/19
18:14
06/19/18
18:14
Periodicals
Breaking Periodicals news story on American Airlines »

American Airlines offers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

ZN

Zion Oil & Gas

$3.13

(0.00%)

18:13
06/19/18
06/19
18:13
06/19/18
18:13
Hot Stocks
Zion Oil & Gas to start operations at Megiddo-Jezreel #1 as soon as June 21 »

Zion Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.43

0.22 (0.38%)

18:10
06/19/18
06/19
18:10
06/19/18
18:10
Hot Stocks
Starbucks says China third party delivery 'was not a good experience' »

Comments taken from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 22

    Jun

EQH

AXA Equitable

$20.94

-0.01 (-0.05%)

18:07
06/19/18
06/19
18:07
06/19/18
18:07
Hot Stocks
Breaking Hot Stocks news story on AXA Equitable »

AXA Equitable reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

EQH

AXA Equitable

$20.94

-0.01 (-0.05%)

18:06
06/19/18
06/19
18:06
06/19/18
18:06
Earnings
AXA Equitable reports Q1 non-GAAP EPS 83c, consensus 82c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

BAESY

BAE Systems

$0.00

(0.00%)

18:06
06/19/18
06/19
18:06
06/19/18
18:06
Periodicals
USMC awards BAE contract to deliver new amphibious vehicles, Reuters says »

The U.S. Marine Corp has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNI

ATN International

$55.30

0.57 (1.04%)

18:04
06/19/18
06/19
18:04
06/19/18
18:04
Hot Stocks
ATN International acquires Geoverse LLC, terms not disclosed »

Geoverse, LLC, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

, GE

General Electric

$12.96

-0.24 (-1.82%)

18:01
06/19/18
06/19
18:01
06/19/18
18:01
Hot Stocks
Walgreens Boots Alliance to replace General Electric in DJIA at open on 6/26 »

Walgreens Boots Alliance…

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

GE

General Electric

$12.96

-0.24 (-1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

HPE

HP Enterprise

$15.90

-0.02 (-0.13%)

18:01
06/19/18
06/19
18:01
06/19/18
18:01
Hot Stocks
HP Enterprise to invest $4B in Intelligent Edge technologies »

Hewlett Packard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.